Univariate analysis | 3.85 | 0.001 | 3.42 | 0.002 | 15.44 | <0.0001 | 14.09 | <0.0001 |
Adjusted for clinical variables | | | | | | | | |
Age | 3.22 | 0.003 | 3.12 | 0.005 | 12.93 | <0.0001 | 11.75 | <0.0001 |
Gender | 3.58 | 0.001 | 3.17 | 0.003 | 15.11 | <0.0001 | 13.85 | <0.0001 |
Age, gender | 2.89 | 0.007 | 2.80 | 0.01 | 12.37 | <0.0001 | 11.26 | <0.0001 |
DM | 3.81 | 0.001 | 3.39 | 0.002 | 15.30 | <0.0001 | 13.99 | <0.0001 |
Known CAD | 3.76 | 0.001 | 3.47 | 0.002 | 13.04 | <0.0001 | 12.29 | <0.0001 |
Previous MI | 3.97 | <0.0001 | 3.52 | 0.002 | 12.76 | <0.0001 | 12.01 | <0.0001 |
Previous PCI | 4.27 | <0.0001 | 3.87 | 0.001 | 14.42 | <0.0001 | 13.45 | <0.0001 |
CAD category* | 3.71 | 0.001 | 3.45 | 0.003 | 13.02 | <0.0001 | 12.26 | <0.0001 |
CAD category*, previous MI | 3.68 | 0.001 | 3.42 | 0.004 | 12.87 | <0.0001 | 12.48 | <0.0001 |
CAD category*, previous MI, aspirin, beta blocker, lipid lowering | 4.22 | <0.0001 | 3.81 | 0.001 | 11.86 | <0.0001 | 11.43 | <0.0001 |
Gender, CAD category*, previous MI, aspirin, beta blocker, lipid lowering | 4.08 | 0.001 | 3.66 | 0.002 | 11.76 | <0.0001 | 11.34 | <0.0001 |
Adjusted for angiographic variables | | | | | | | | |
CCS score (n=223/115) | 4.27 | 0.003 | 3.77 | 0.006 | 12.06 | <0.0001 | 11.03 | <0.0001 |
Number of stenotic vessels (n=210/108) | 4.62 | 0.005 | 4.52 | 0.006 | 9.19 | 0.001 | 9.28 | 0.001 |
CCS score, number of stenotic vessels (n=210/108) | 4.52 | 0.007 | 4.18 | 0.007 | 9.89 | 0.001 | 9.49 | 0.002 |
Adjusted for scintigraphic variables | | | | | | | | |
At-rest LVEF (n=648/147) | 2.87 | 0.08 | 2.97 | 0.08 | 12.78 | <0.0001 | 12.86 | <0.0001 |
Post-stress LVEF (n=687/123) | 2.70 | 0.09 | 2.80 | 0.10 | 12.74 | <0.0001 | 12.93 | <0.0001 |
Adjusted for selected variables of all types | | | | | | | | |
Gender, CAD category*, previous MI, aspirin, beta blocker, lipid lowering, CCS score (n=223/115) | 4.55 | 0.004 | 3.48 | 0.009 | 29.29 | <0.0001 | 26.69 | <0.0001 |
Gender, CAD category*, previous MI, aspirin, beta blocker, lipid lowering, number of stenotic vessels (n=210/108) | 4.30 | 0.02 | 3.79 | 0.03 | 11.70 | 0.001 | 11.80 | 0.001 |
Gender, CAD category*, previous MI, aspirin, beta blocker, lipid lowering, CCS score, number of stenotic vessels (n=210/108) | 4.14 | 0.02 | 3.31 | 0.06 | 20.86 | 0.001 | 20.23 | 0.001 |